| scholarly article | Q13442814 |
| P50 | author | Marcela F. Pasetti | Q56380831 |
| P2093 | author name string | Sharon M Tennant | |
| A Duncan Steele | |||
| P2860 | cites work | The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan | Q36288804 |
| Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium? | Q36388856 | ||
| The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease | Q36505159 | ||
| Clinical and Environmental Surveillance for Vibrio cholerae in Resource Constrained Areas: Application During a 1-Year Surveillance in the Far North Region of Cameroon | Q36644427 | ||
| Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections | Q37167794 | ||
| Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants | Q38422118 | ||
| Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh | Q38501139 | ||
| Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407 | Q38941412 | ||
| Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial | Q40295575 | ||
| Epidemiologic, Virologic, and Host Genetic Factors of Norovirus Outbreaks in Long-term Care Facilities | Q40385288 | ||
| Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults | Q41168503 | ||
| Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study | Q41637482 | ||
| Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults | Q41743964 | ||
| In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation | Q42120657 | ||
| Cholera in Africa: new momentum in fighting an old problem | Q42214959 | ||
| Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine | Q43716574 | ||
| Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population | Q68134308 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Rotavirus vaccines:an update | Q82337129 | ||
| Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak | Q28552894 | ||
| The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems | Q30300580 | ||
| Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries | Q30416070 | ||
| Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology | Q30628895 | ||
| Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium | Q33769332 | ||
| Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults | Q34120926 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Etiology of childhood diarrhea after rotavirus vaccine introduction: a prospective, population-based study in Nicaragua | Q34437732 | ||
| Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines | Q35271174 | ||
| The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 yea | Q35322779 | ||
| A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas | Q35598235 | ||
| The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study | Q35754539 | ||
| Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study | Q35880450 | ||
| Evaluation in Cameroon of a Novel, Simplified Methodology to Assist Molecular Microbiological Analysis of V. cholerae in Resource-Limited Settings. | Q35886885 | ||
| Serological Correlates of Protection against a GII.4 Norovirus | Q35901978 | ||
| Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB | Q35924773 | ||
| Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea | Q35998767 | ||
| Global age distribution of pediatric norovirus cases | Q36181393 | ||
| P433 | issue | 4 | |
| P921 | main subject | maternal health | Q6786626 |
| P304 | page(s) | 272-281 | |
| P577 | publication date | 2016-03-02 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Highlights of the 8th International Conference on Vaccines for Enteric Diseases: the Scottish Encounter To Defeat Diarrheal Diseases | |
| P478 | volume | 23 |
| Q91827516 | A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children |
| Q93167721 | Childhood diarrhoeal diseases in developing countries |
| Q37477196 | Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. |
| Q57945015 | The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT |
Search more.